FDA Moves to Reevaluate Several Peptides American Med Spa Association Peptides are unproven as health aids. FDA may unleash them anyway FDA to weigh easing limits on unproven peptides The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be FDA Peptide Update: Category 2 Removals Explained RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion